These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 36243806)

  • 21. Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma.
    Bian Y; Liu YF; Jiang H; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Li Q; Wang L; Lu J; Shao C
    Abdom Radiol (NY); 2021 Oct; 46(10):4800-4816. PubMed ID: 34189612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics.
    Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X
    J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
    Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
    Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
    Jimenez JE; Abdelhafez A; Mittendorf EA; Elshafeey N; Yung JP; Litton JK; Adrada BE; Candelaria RP; White J; Thompson AM; Huo L; Wei P; Tripathy D; Valero V; Yam C; Hazle JD; Moulder SL; Yang WT; Rauch GM
    Eur J Radiol; 2022 Apr; 149():110220. PubMed ID: 35193025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preoperative radiogenomic model based on quantitative heterogeneity for predicting outcomes in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy.
    Zhou J; Bai Y; Zhang Y; Wang Z; Sun S; Lin L; Gu Y; You C
    Cancer Imaging; 2024 Jul; 24(1):98. PubMed ID: 39080809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning-based MRI radiomics for assessing the level of tumor infiltrating lymphocytes in oral tongue squamous cell carcinoma: a pilot study.
    Ren J; Yang G; Song Y; Zhang C; Yuan Y
    BMC Med Imaging; 2024 Feb; 24(1):33. PubMed ID: 38317076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of PD-L1 Attenuates the Positive Impacts of High-level Tumor-infiltrating Lymphocytes on Prognosis of Triple-negative Breast Cancer.
    Zhu X; Zhang Q; Wang D; Liu C; Han B; Yang JM
    Cancer Biol Ther; 2019; 20(8):1105-1112. PubMed ID: 30929569
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors.
    Baram T; Erlichman N; Dadiani M; Balint-Lahat N; Pavlovski A; Meshel T; Morzaev-Sulzbach D; Gal-Yam EN; Barshack I; Ben-Baruch A
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.
    Quintana Á; Peg V; Prat A; Moliné T; Villacampa G; Paré L; Galván P; Dientsmann R; Schmid P; Curigliano G; Muñoz-Couselo E; Perez-García J; Marti M; Blanco-Heredia J; Anjos CD; Vazquez M; De Mattos-Arruda L; Cortés J
    Eur J Cancer; 2021 May; 148():134-145. PubMed ID: 33743482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.
    Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
    BMC Cancer; 2021 Mar; 21(1):286. PubMed ID: 33726701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study.
    Ma J; Chen K; Li S; Zhu L; Yu Y; Li J; Ma J; Ouyang J; Wu Z; Tan Y; He Z; Liu H; Pan Z; Li H; Liu Q; Song E
    Eur Radiol; 2024 Mar; 34(3):1774-1789. PubMed ID: 37658888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.
    Pinard C; Debled M; Ben Rejeb H; Velasco V; Tunon de Lara C; Hoppe S; Richard E; Brouste V; Bonnefoi H; MacGrogan G
    Breast Cancer Res Treat; 2020 Jan; 179(1):11-23. PubMed ID: 31529299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).
    Tomioka N; Azuma M; Ikarashi M; Yamamoto M; Sato M; Watanabe KI; Yamashiro K; Takahashi M
    Breast Cancer; 2018 Jan; 25(1):34-42. PubMed ID: 28488168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between radiomics features of DCE-MRI and CD8
    Huang H; Li Z; Xia Y; Zhao Z; Wang D; Jin H; Liu F; Yang Y; Shen L; Lu Z
    Pathol Oncol Res; 2023; 29():1611001. PubMed ID: 37342362
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
    Arefan D; Hausler RM; Sumkin JH; Sun M; Wu S
    BMC Cancer; 2021 Apr; 21(1):370. PubMed ID: 33827490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography.
    Feng Q; Hu Q; Liu Y; Yang T; Yin Z
    BMC Cancer; 2020 Jun; 20(1):579. PubMed ID: 32571245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep learning-based and BI-RADS guided radiomics model for automatic tumor-infiltrating lymphocytes evaluation in breast cancer.
    Lu X; Jia Y; Zhang H; Wu R; Zhao W; Yao Z; Nie F; Ma Y
    Br J Radiol; 2024 Jul; ():. PubMed ID: 38995740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics.
    Jiang W; Wu R; Yang T; Yu S; Xing W
    Cancer Med; 2023 Dec; 12(24):21861-21872. PubMed ID: 38083903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.